Watch These Hot Ones: SINA Corporation (NASDAQ:SINA), Symantec Corporation (NASDAQ:SYMC), Gilead Sciences (NASDAQ:GILD), PulteGroup (NYSE:PHM)

ArcelorMittal SA (ADR) (NYSE:MT) ended the last trading day at $4.04. Company weekly volatility is calculated as 3.17% and price to cash ratio as 1.86. ArcelorMittal SA (ADR) (NYSE:MT) showed a weekly performance of -12.36%.

On 04 January, SINA Corporation (NASDAQ:SINA) shares decreased -3.02% and was closed at $47.91. SINA EPS growth in last 5 year was -18.70%. SINA Corporation (NASDAQ:SINA) year to date (YTD) performance is -3.02%.

Vetr cut shares of SINA Corporation (NASDAQ:SINA) from a hold rating to a sell rating in a research report released on Monday morning, AnalystRatings.NET reports. Vetrcurrently has $49.16 target price on the stock.

Symantec Corporation (NASDAQ:SYMC) shares decreased -0.76% in last trading session and ended the day at $20.84. SYMC Gross Margin is 82.40% and its has a return on assets of 5.20%. Symantec Corporation (NASDAQ:SYMC) quarterly performance is 6.86%.

Symantec Corporation (NASDAQ:SYMC) and The Carlyle Group (NASDAQ: CG) announced that they expect to close Carlyle’s acquisition of Veritas on January 29, 2016, subject to the satisfaction of customary closing conditions. The closing was previously expected to take place on January 1, 2016.

Gilead Sciences Inc. (NASDAQ:GILD) caters to the Healthcare space. It has a net profit margin of 53.80% and weekly performance is -5.38%. On the last day of trading company shares ended up at $98.01. Gilead Sciences Inc. (NASDAQ:GILD) distance from 50-day simple moving average (SMA50) is -1.90%.

On 2 January, Gilead Sciences Inc. (NASDAQ:GILD) has grown to be a leading biotech company in the past few years, mostly on the back of the phenomenal success of its hepatitis C franchise. The drug-maker’s two revolutionary HCV drugs, Harvoni and Sovaldi, are two of the fastest-growing medicines in history, boasting cure rates of 8-24 weeks, down from a prior 24-48 week treatment period. However, the drugs seem to be approaching market saturation, with Gilead predicting flat HCV sales next year.

PulteGroup, Inc. (NYSE:PHM) caters to the Industrial Goods space. It has a net profit margin of 8.40% and weekly performance is -5.82%. On the last day of trading company shares ended up at $17.16. PulteGroup, Inc. (NYSE:PHM) distance from 50-day simple moving average (SMA50) is -6.44%.

PulteGroup, Inc. (NYSE:PHM) announced that it plans to purchase a massive portfolio of land and houses from John Wieland Homes and Neighborhoods for between $430 million and $450 million.